The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout

By sjmartinez • March 12, 2024

Yokose C, McCormick N, Abhishek A, Dalbeth N, Pascart T, Lioté F, Gaffo A, FitzGerald J, Terkeltaub R, Sise ME, Januzzi JL, Wexler DJ, Choi HK. The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout. Nat Rev Rheumatol. 2024 Mar 12. doi: 10.1038/s41584-024-01092-x. Epub ahead of print. PMID: 38472344.

Tags: Publications, Rheumatology, Veterans Administration

Evaluation of the Reliability and Validity of the Retirement Knowledge Scale (RKS)

Blanco LR, Hays RD. Evaluation of the Reliability and Validity of the Retirement Knowledge Scale (RKS). J Retire. 2024 Fall;12(2):76-94. doi: 10.3905/jor.2024.1.164. Epub 2024 Oct[...]

Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease

Ko M, Barai R, Brent G. Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease. Cureus. 2024 Oct 15;16(10):e71551. doi: 10.7759/cureus.71551.[...]

Patient-Identified Treatment Goals for Psoriatic Disease: Results From a US Patient Survey

Armstrong A, Levit NA, Schneider B, Seiden R, Shi L, Kaplan B, Wu JJ. Patient-Identified Treatment Goals for Psoriatic Disease: Results From a US Patient[...]